393 related articles for article (PubMed ID: 12216107)
41. Metabolic assessment of intracranial tuberculomas using 11C-methionine and 18F-FDG PET/CT.
D'Souza MM; Sharma R; Jaimini A; Panwar P; Bansal A; Tripathi M; Varshney R; Pandey S; Mondal A
Nucl Med Commun; 2012 Apr; 33(4):408-14. PubMed ID: 22301451
[TBL] [Abstract][Full Text] [Related]
42. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
43. Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.
Kawase Y; Yamamoto Y; Kameyama R; Kawai N; Kudomi N; Nishiyama Y
Mol Imaging Biol; 2011 Dec; 13(6):1284-9. PubMed ID: 21042866
[TBL] [Abstract][Full Text] [Related]
44. Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT.
Sasaki M; Kuwabara Y; Yoshida T; Fukumura T; Morioka T; Nishio S; Fukui M; Masuda K
J Nucl Med; 1998 Jun; 39(6):974-7. PubMed ID: 9627328
[TBL] [Abstract][Full Text] [Related]
45. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
Tomura N; Saginoya T; Goto H
J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
[TBL] [Abstract][Full Text] [Related]
46. 18F alpha-methyl tyrosine PET studies in patients with brain tumors.
Inoue T; Shibasaki T; Oriuchi N; Aoyagi K; Tomiyoshi K; Amano S; Mikuni M; Ida I; Aoki J; Endo K
J Nucl Med; 1999 Mar; 40(3):399-405. PubMed ID: 10086702
[TBL] [Abstract][Full Text] [Related]
47. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
48. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.
Nettelbladt OS; Sundin AE; Valind SO; Gustafsson GR; Lamberg K; Långström B; Björnsson EH
J Nucl Med; 1998 Apr; 39(4):640-7. PubMed ID: 9544671
[TBL] [Abstract][Full Text] [Related]
49. Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Hustinx R; Smith RJ; Benard F; Bhatnagar A; Alavi A
Eur J Nucl Med; 1999 Nov; 26(11):1501-9. PubMed ID: 10552096
[TBL] [Abstract][Full Text] [Related]
50. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging.
Ohtani T; Kurihara H; Ishiuchi S; Saito N; Oriuchi N; Inoue T; Sasaki T
Eur J Nucl Med; 2001 Nov; 28(11):1664-70. PubMed ID: 11702108
[TBL] [Abstract][Full Text] [Related]
51. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH
Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944
[TBL] [Abstract][Full Text] [Related]
52. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine.
Pirotte B; Goldman S; David P; Wikler D; Damhaut P; Vandesteene A; Salmon L; Brotchi J; Levivier M
Acta Neurochir Suppl; 1997; 68():133-8. PubMed ID: 9233429
[TBL] [Abstract][Full Text] [Related]
53. 11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.
Yamamoto Y; Nishiyama Y; Kimura N; Kameyama R; Kawai N; Hatakeyama T; Kaji M; Ohkawa M
Mol Imaging Biol; 2008 Sep; 10(5):281-7. PubMed ID: 18543041
[TBL] [Abstract][Full Text] [Related]
54. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H
J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935
[TBL] [Abstract][Full Text] [Related]
55. An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using
Takahashi M; Soma T; Mukasa A; Koyama K; Arai T; Momose T
Ann Nucl Med; 2017 Apr; 31(3):250-259. PubMed ID: 28194701
[TBL] [Abstract][Full Text] [Related]
56. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
57. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
[TBL] [Abstract][Full Text] [Related]
58. Comparative evaluation of
Norikane T; Mitamura K; Yamamoto Y; Manabe Y; Murao M; Arai-Okuda H; Hatakeyama T; Miyake K; Nishiyama Y
J Neurooncol; 2024 Jan; 166(1):195-201. PubMed ID: 38160415
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy.
Laser BS; Merchant TE; Indelicato DJ; Hua CH; Shulkin BL; Snyder SE
Neuro Oncol; 2013 Apr; 15(4):506-10. PubMed ID: 23408862
[TBL] [Abstract][Full Text] [Related]
60. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors.
Kaplan AM; Bandy DJ; Manwaring KH; Chen K; Lawson MA; Moss SD; Duncan JD; Wodrich DL; Schnur JA; Reiman EM
J Neurosurg; 1999 Nov; 91(5):797-803. PubMed ID: 10541237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]